Detection of Drug-induced Interstitial Lung Disease Caused by Cancer Treatment Using Electronic Nose Exhaled Breath Analysis
Ann Am Thorac Soc
.
2024 Jun;21(6):989-992.
doi: 10.1513/AnnalsATS.202401-112RL.
Authors
Iris G van der Sar
1
,
Marlies S Wijsenbeek
1
,
Daphne W Dumoulin
1
,
Agnes Jager
1
,
Astrid A M van der Veldt
1
,
Mariska J P Rossius
1
,
Anne-Marie C Dingemans
1
,
Catharina C Moor
1
Affiliation
1
Erasmus University Medical Center Rotterdam, The Netherlands.
PMID:
38526585
DOI:
10.1513/AnnalsATS.202401-112RL
No abstract available
Publication types
Letter
Case Reports
MeSH terms
Antineoplastic Agents / adverse effects
Breath Tests* / methods
Electronic Nose*
Exhalation
Humans
Lung Diseases, Interstitial* / chemically induced
Lung Diseases, Interstitial* / diagnosis
Neoplasms / drug therapy
Substances
Antineoplastic Agents
Grants and funding
AstraZeneca/United States
Daiichi-Sankyo/United States